Anthrax as a biological weapon, 2002: updated recommendations for management
about
Beetroot-pigment-derived colorimetric sensor for detection of calcium dipicolinate in bacterial sporesA systematic screen of FDA-approved drugs for inhibitors of biological threat agentsGram-positive and gram-negative bacterial toxins in sepsis: a brief reviewAnthrax letters in an open office environment: effects of selected CDC response guidelines on personal exposure and building contaminationMultigeneration cross contamination of mail with Bacillus species spores by tumblingParticle release from respirators, part I: determination of the effect of particle size, drop height, and loadRapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin G in serum and whole bloodBacillus anthracis contamination and inhalational anthrax in a mail processing and distribution centerVaccines for preventing anthraxThe primary care differential diagnosis of inhalational anthraxAnthrax infectionIntensity of rainfall and severity of melioidosis, AustraliaRisk factors associated with anthrax outbreak in animals in North Dakota, 2005: a retrospective case-control studyRaxibacumabAnthrax vaccine and public health policyHuman capillary morphogenesis protein 2 functions as an anthrax toxin receptorInvestigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findingsAnthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxinEffective antiprotease-antibiotic treatment of experimental anthraxDetermination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassayOpening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health responseMultigeneration cross-contamination of mail with Bacillus anthracis sporesCytoskeleton as an emerging target of anthrax toxinsPhysiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxinsStructure of the Type III Pantothenate Kinase from Bacillus anthracis at 2.0 Å Resolution: Implications for Coenzyme A-Dependent Redox Biology † , ‡Cellular Functions and X-ray Structure of Anthrolysin O, a Cholesterol-dependent Cytolysin Secreted by Bacillus anthracisCrystal Structure of Bacillus anthracis Dihydrofolate Reductase with the Dihydrophthalazine-Based Trimethoprim Derivative RAB1 Provides a Structural Explanation of Potency and SelectivityAlternative pre-approved and novel therapies for the treatment of anthraxAirborne infection with Bacillus anthracis--from mills to mailMurine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibilityIs in vitro antibiotic combination more effective than single-drug therapy against anthrax?Antitoxin Treatment of Inhalation Anthrax: A Systematic ReviewProphylaxis and treatment of anthrax in pregnant womenProtective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis.Use of an in vitro pharmacodynamic model to derive a linezolid regimen that optimizes bacterial kill and prevents emergence of resistance in Bacillus anthracisNovel strategies for enhanced removal of persistent Bacillus anthracis surrogates and Clostridium difficile spores from skinBioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatmentSyndromic surveillance and bioterrorism-related epidemicsSurface sampling of spores in dry-deposition aerosols
P2860
Q21090717-D735DBE5-D13F-483C-AC9E-C92164E1404DQ21559667-20CF5EA3-5B76-49EF-AE3A-ABCDC5A5B507Q22305427-9F3DE646-6EC6-4C1E-8110-BA9474A481C1Q23910424-BAE0B5AA-7B26-4E87-9903-B8F33EB5B1F5Q23914492-B0C6D4EB-D605-4E3C-A465-3177F4715145Q23914587-92DA093B-49B3-4E50-9849-514197207AC4Q23919993-C6417B82-DCC6-488D-A056-B5AB7C766EF4Q23923522-8B57A3D3-002E-4AA2-B296-5608ECE5DE59Q24241812-967BB6EC-069B-4A21-B7ED-F80A0495E5D6Q24544609-EDC99CD7-1758-4B83-817A-892977D2A789Q24616676-8F20EDF0-4283-49E6-A052-168700F8D2A6Q24630163-EC8709D4-31A4-4B94-9F96-F4B201BDDD73Q24642441-AB676C10-5ED7-4F93-8203-C4EF265A8C42Q24644111-90C0C8F8-6CBF-47C0-9CB5-B5028F9A488CQ24675688-8733F3EF-DB8D-4665-97C1-1DF8B1746035Q24677716-F7BFACCF-5A0F-4F7C-A8D4-588EE19EC53BQ24718884-121CA1E2-2D38-41DB-A0B1-12E92D2F2F07Q24796044-E19C5CC6-722D-41F9-8DAE-C727027A587BQ24799393-37CE7F12-82FE-4CFF-9F27-4048BB4F79F3Q25018214-FD2FB3C1-AE16-48E6-8DCA-DC9DB12A6C25Q26155001-13C855C8-0430-4D85-96EA-1ADB8BFCCCE6Q26343874-0B6A480D-6376-4CC2-98E8-7299937330E5Q27005620-3F0A0AB1-547F-4D89-B7DF-4658658068F8Q27640171-5AB7BACA-5F75-4B44-99FF-9D55445C6BE4Q27643910-ADA80029-6E43-4D53-8F2E-74355023561DQ27654239-FF043D78-F449-4151-A98E-C327BAFF079CQ27654731-84F48570-947A-4EBD-A7C9-E2FFB8B42EBDQ28075453-D9587FF1-3053-4605-BC96-C93DF52BEE48Q28383236-3A5D9AC0-190B-46CB-80F6-288B6A31D05FQ28383436-5F648598-6E68-4A97-947C-66BC32C71263Q28383505-85223CB5-F3D7-46FD-9B59-1D1A276B32BDQ28383765-A6BE60C6-A462-41A8-A80C-7FE4DC1D4E34Q28383774-F3B33CF7-C851-484C-836B-225B1F2A1784Q28384322-630D4F19-C188-4397-9A26-ECBA2F4725FDQ28384759-E47F2086-FF79-459E-BE0B-A4F1CE74543FQ28385028-2DC9D5ED-20D3-488A-8F14-ECC1B6709CA3Q28385171-0739898B-B247-4549-AD2D-4D0A669736EDQ28385233-425430F5-DA87-4EFC-973C-EFBAA1EC8C99Q28386064-3C76BCA1-C8FA-4851-90D6-45E8F6FE9F9CQ28386887-39CCD0A4-C4CE-47D5-B50E-B4254081CACD
P2860
Anthrax as a biological weapon, 2002: updated recommendations for management
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Anthrax as a biological weapon, 2002: updated recommendations for management
@ast
Anthrax as a biological weapon, 2002: updated recommendations for management
@en
type
label
Anthrax as a biological weapon, 2002: updated recommendations for management
@ast
Anthrax as a biological weapon, 2002: updated recommendations for management
@en
prefLabel
Anthrax as a biological weapon, 2002: updated recommendations for management
@ast
Anthrax as a biological weapon, 2002: updated recommendations for management
@en
P2093
P3181
P356
P1476
Anthrax as a biological weapon, 2002: updated recommendations for management
@en
P2093
Bartlett JG
Friedlander AM
Gerberding J
Henderson DA
Inglesby TV
P304
P3181
P356
10.1001/JAMA.287.17.2236
P407
P577
2002-05-01T00:00:00Z